Ensysce Biosciences Inc. held annual shareholder meeting
I'm PortAI, I can summarize articles.
Ensysce Biosciences Inc. held its annual shareholder meeting on January 7, 2026. Stockholders approved the issuance of common stock shares and the exercise of warrants. An amendment to increase shares under the Omnibus Incentive Plan was also approved. The election of Class I Directors William Chang and Lee Rauch was confirmed, and Baker Tilly US, LLP was appointed as the independent accounting firm for the fiscal year ending December 31, 2025. One proposal regarding the adjournment of the meeting was not voted on.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments